Sucampo Pharmaceuticals, Inc. (SCMP) Misses Q1 EPS by 2c
Tweet
Share
E-mailGet Alerts SCMP Hot Sheet
Price: $18.00 --0%
Financial Fact:
Research and development: 9.98M
Today's EPS Names:
MSGM, SMID, VISL, More
Financial Fact:
Research and development: 9.98M
Today's EPS Names:
MSGM, SMID, VISL, More
Join SI Premium – FREE
Sucampo Pharmaceuticals, Inc. (NASDAQ: SCMP) reported Q1 EPS of $0.02, $0.02 worse than the analyst estimate of $0.04. Revenue for the quarter came in at $22.2 million versus the consensus estimate of $24.19 million.
For earnings history and earnings-related data on Sucampo Pharmaceuticals, Inc. (SCMP) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
- Yum! Brands (YUM) PT Lowered to $180 at Argus
- UBS: 'We Believe Dollar Tree (DLTR) is Turning From a Transformation to a Growth Story'
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
